1–2 of 2 results for semaglutide
Risk of Sight-Threatening Diabetic Retinopathy With GLP-1 RA Use: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide
Andrew J. Barkmeier, MD
Annual Meeting Talks
2025
Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022